Kenai Therapeutics Funding: $100M Raised, Series A (2024)
Kenai Therapeutics is based in California. It has raised $100M in total funding. Latest round: Series A.
Kenai Therapeutics funding overview
Kenai Therapeutics is based in California. Kenai Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2024. The round record for Kenai Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include The Column Group, Cure Ventures, Alaska Permanent Fund. 3 distinct backers are named across the disclosed rounds.
Kenai Therapeutics at a glance
Total raised
$100M
Latest round
Series A
Latest round date
March 2024
Headquarters
California
Notable investors
The Column Group, Cure Ventures, Alaska Permanent Fund
Frequently asked about Kenai Therapeutics funding
How much has Kenai Therapeutics raised?
Kenai Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Kenai Therapeutics?
The Column Group, Cure Ventures, Alaska Permanent Fund are named among the investors backing Kenai Therapeutics.
What was the latest Kenai Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2024.
Where is Kenai Therapeutics based?
Kenai Therapeutics is based in California.
When did Kenai Therapeutics last raise?
The last disclosed Kenai Therapeutics round closed in March 2024 at Series A.
We update the Kenai Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in California and their backers are listed below.
